The intranasal route was used to study Candida albicans infections in mice.
INTRODUCTION
Candida albicans is frequently isolated from the commensal flora of healthy humans. However, C. albicans is also a significant cause of opportunistic infections and has emerged in recent years as a major cause of nosocomial infections (Pfaller, 1996) . C. albicans infection in the immunocompromised host often involves colonization of vital organs such as the brain, liver and kidneys (Dupont, 1995; Klingspor et al., 1996) . More common is the development of chronic mucosal candidiasis in the oropharyngeal or urinogenital tracts, particularly in HIV-infected patients (Klein et al., 1984; Samaranayake & Holmstrop, 1989) . Experimental approaches to investigating the immunology and pathogenicity of C. albicans have been substantially limited by the range of small animal models available for in uivo studies. The most frequently reported infection model utilizes intravenous (i.v.) challenge of inbred mice which can lead to a reproducible systemic infection with serious renal and cerebral compromise (Papadimitriou & Ashman, 1986; Romani et al., 1993) . Yet, clinical C. albicans infections most frequently develop from a mucosal site, with the gastrointestinal and urinogenital tracts serving as important C. albicans reservoirs. In rodents C. albicans has a limited ability to colonize the intestinal tract and to cause systemic disease after oral challenge. Significant colonization of the gastro-intestinal mucosa only occurs in adult immunocompetent mice if prolonged antibiotic treatment is given before and after C. albicans oral or intragastric challenge (Cenci et al., 1995 ; Greenfield & Joyce, 1993 ; Helstrom & Balish, 1979) . Germ-free mice orally infected with C. albicans may develop localized mucosal infections in the oro-intestinal tract (Jensen et al., 1996; Lacasse et al., 1993) . However, intestinal infections resulting from oral other organs, except if the mice are artificially immuno- (Jensen et al., 1993 (Jensen et al., , 1994 ; Samonis et al., 1994 (Mallett et al., 1995 (Mallett et al., , 1993 van de Verg et al., 1995; Voino-Yasenetsky & Voino-Yasenetsky, 1962) . This model has been exploited to study the immunobiology of shigellosis and to evaluate potential vaccines (Barzu et al., 1996; Noriega et al., 1996; Phalipon et al., 1995; Sizemore et al., 1997) . There is evidence from calves and pigs that the upper respiratory tract is also a susceptible site for Salmonella invasion. Salmonella dublin and Salmonella typhirnurium can spread systemically to organs such as the liver, spleen and intestines upon challenge through the upper respiratory tract Gray et al., 1995; Roof & Doitchinoff, 1995; Stabel et al., 1995) . Salmonella typhi, a highly host-restricted human intestinal pathogen, is incapable of inducing a progressive systemic disease in mice following oral inoculation. However, when delivered intranasally, s.
typhi can elicit strong systemic and mucosal immune responses which can be used to predict the behaviour of the strain in human oral inoculation trials (Barry et al., 1996; Galen et al., 1997) .
Challenge through the respiratory tract and intranasal (i.n.) challenge in particular, has not been explored in experimental models of C. albicans infection as extensively as oro-gastric challenge. Intratracheal deposition has been used to infect mice (Hurley, 1966; Nuget & Onofrio, 1983; Sawyer, 1990 ) and concomitant systemic spread was only observed if mice were treated with steroids after challenge (Hurley, 1966; Nuget & Onofrio, 1983) . Similarly, i.n. challenge has been reported to result in systemic dissemination in mice rendered neutropenic by cyclophosphamide treatment (Fallon et al., 1997) . In this study we have shown that, following i.n. infection of immunocompetent adult mice, C. albicans can elicit an inflammatory response in the lungs and subsequently disseminate to kidneys, liver and spleen in a susceptible (DBA/2) but not in a resistant (BALB/c) mouse strain. We have analysed the antic. albicans immune responses elicited by i.n. challenge in these mice and have described the differences found in mucosal and systemic antibody and cellular responses.
We propose that the model described here could be used to investigate the process of systemic C. albicans spread from mucosal surfaces and the role of mucosal immune responses in candidiasis. . This strain is germ-tube-positive and chlamydospore-positive and yields the chlamydospore presentation profile typical of C. albicans. It yields bluegreen colonies on Chromagar Candida medium, grows well at 30, 37 and 42 "C and its carbohydrate assimilation profile is characteristic of C. albicans. MG3 has DNA fingerprint characteristics typical of C. albicans serotype A, has the ability to germinate in the presence of bovine serum and is resistant to cycloheximide. The strain was routinely maintained in Potato Dextrose agar (PDA; Difco). Stocks of live yeast to be used for animal infections were prepared from 18-h-old cultures of C. albicans MG3 in Sabouraud broth (Difco) at 37 "C (cell density of at least 1 x 108 c.f.u. ml-l). Yeast cells were harvested by centrifugation at 800g for 10 min. After three washes with endotoxin-free PBS (Sigma), yeast cells were resuspended in approximately 0.2 vols endotoxin-free PBS, aliquoted, snap-frozen and stored at -70 "C. Aliquots were thawed immediately before inoculation and their concen- or a Stomacher (other organs). Viable C. albicans were counted by plating different dilutions of the homogenates on PDA, as described above. For assessment of LD,,, groups of 6 mice were infected either intranasally or intravenously with maximum doses of 3 x 107 or 1 x lo6 live yeast cells, respectively. Mice were kept under observation for 45 (i.n. challenge) or 52 (i.v. challenge) d and deaths were recorded on a daily basis. The Reed-Muench method was used to calculate LD,, (Welkos & O'Brien, 1994) .
METHODS
Histology. Lungs from mice infected 4 h previously with 1 x lo7 yeast cells were fixed in 10% (v/v) neutral buffered formalin, embedded in paraffin wax and sectioned. Sections were either stained with hematoxylin and eosin or immunostained using the Vectastain ABC Reagent (Anti-Rabbit IgG Kit; Vector Laboratories). The primary antiserum used was a commercial rabbit polyclonal antiserum against C. albicans give an A,,, above the mean A 4 9 2 of naive sera + 2 x SEM.
Specific anti-C. albicans IgA was measured in lung lavages from groups of 4-6 mice obtained as described previously (Douce et al., 1995) . T o compare the levels of specific anti-C. albicans IgA in the lavages, titres were expressed as ELISA units (EU) (pg total 1gA)-', thus preventing errors due to differences in total content of IgA. The total content of IgA present on pooled lavage samples was assessed in a sandwich ELISA using plates coated with anti-mouse IgA antibody as described by Elson et al. (1984) . The content of specific anti-C. albicans IgA on lavages was measured using the same ELISA as for serum antibodies. The number of EU present on the lavages was established by comparison to a reference mouse serum that contained a high titre of anti-C. albicans IgA antibodies, to which an arbitrary concentration (EU ml-l) was assigned.
RESULTS
Susceptibility of BALB/c and DBA/2 mice to C. albicans MG3 i.n. challenge C. albicans MG3 challenge through either the i.v. or i.n.
routes showed that BALB/c mice were more resistant to C. albicans MG3 infection than DBA/2 mice ( Table 1) .
The i.v. data, included as control, agree with previously published observations (Ashman et al., 1993 ; Hector et al., 1982; Romani et al., 1993) . All DBA/2 mice intravenously challenged with a dose of lo5 yeast cells succumbed to the infection, whereas more than 50 % of the BALB/c mice survived a similar challenge. The i.v. LD50 for BALB/c mice was at least four times greater than for DBA/2 mice ( Table 1) . Intranasally challenged BALB/c mice could survive a dose of 3 x lo' yeast cells, whereas more than half of the DBA/2 mice succumbed to the same challenge. The i.n. LD,, for BALB/c mice was at least two times higher than for DBA/2 mice ( Table 1) . Examination of dead DBA/2 mice after i.n. challenge showed heavy C. albicans MG3 loads in the kidneys, comparable to those observed after i.v. infection (data not shown). BALB/c mice that died following i.v. challenge also showed heavy C. albicans loads on their kidneys ( > 1 x lo4 c.f.u. per organ).
Kinetics of infection after i.n. challenge
Following i.n. challenge with 1 x lo' live yeast cells, viable C. albicans MG3 were recovered from the lungs of BALB/c and DBA/2 mice at different time points (Fig.  1) . The course of lung infection was very similar in both mouse strains during the first 48 h after challenge. However, by day 5 the C. albicans load in the lungs of DBA/2 mice was significantly higher (approx. 50-fold higher) than that of BALB/c mice (P < 0-05, as calculated by Student's t test). By day 7 , no significant difference was observed in the number of C. albicans recovered from the lungs of both strains of mice.
BALB/c mice were not only able to clear C. albicans from their lungs more rapidly, but they could also avoid significant C. albicans spread to other organs such as kidneys, liver ( Table 2 , Fig. 1) and spleen (Table 2) . In contrast, the majority of DBA/2 mice exhibited significant colonization of one or more of these organs (Table   2 ). C. albicans colonization of the kidneys and liver peaked between 2 and 5 d after challenge (Fig. 1) . A positive correlation was found between the C. albicans load in the lungs and that of kidneys or liver (data not shown).
Histopathology of C. albicans infection in the lung
The lungs of mice were examined after i.n. challenge to determine the early fate of C. albicans MG3 cells within host tissues. At 4 h after challenge there were detectable C. albicans MG3 adjacent to the respiratory bronchioles in the lungs of both BALB/c and DBA/2 mice. No discernible differences in the histology of lungs prepared from C. albicans MG3-infected DBA/2 or BALB/c mice were found at this stage of the infection. C. albicans MG3 in hyphal and yeast forms were visible in airways and also in surrounding tissue by immunostaining with a C. albicans-specific rabbit serum and hematoxylin and eosin. An inflammatory infiltrate, composed of polymorphonuclear lymphocytes and mononuclear cells, was also detectable in sections from both mouse strains (data not shown).
Cellular response against C. albicans MG3 upon i.n.
challenge Anti-C. albicans cellular responses, as determined in splenocyte proliferation assays, were detected in both DBA/2 and BALB/c mice from 7 d after i.n. challenge.
The response peaked on day 7 in BALB/c mice and on day 14 in DBA/2 mice and remained detectable for at least SO d after challenge in both strains of mice (data not shown). The profiles of cytokine secretion by the proliferating splenocytes showed differences (Fig. 2) . While both splenocyte populations produced IFNy and ILlO, production of IL4 and ILS was only detected in BALB/c, but not DBA/2, splenocytes. Similar results were obtained with splenocytes harvested 7 , 14 (Fig. 2) or 21 d (data not shown) after challenge. As expected, all the cytokines measured were secreted by DBA/2 and BALB/c splenocyte populations in response to ConA stimulation (data not shown).
Antibody response to C. albicans MG3
Humoral responses against C. albicans MG3 were detected in both BALB/c and DBA/2 mice following C. albicans MG3 i.n. challenge. A significant anti-C. albicans IgG response appeared earlier in DBA/2 mice (day 7) than in BALB/c mice (day 14) (Fig. 3) . The antibody response did not significantly change over a period of 90 d (data not shown). IgG1, IgG2a, IgG2b and IgG3 antibody subclasses contributed to the anti-C. albicans response in BALB/c mice, although IgG2a appeared to be slightly dominant. In contrast, in DBA/2 mice, IgG2b was clearly the predominant IgG subclass and anti-C. albicans IgG1 was not detected.
Following i.n. challenge, BALB/c, but not DBA/2 mice exhibited a systemic IgA response against C. albicans MG3 (Fig. 3) . The titre of the response in BALB/c mice was higher on day 14 than on day 7. The local production of IgA paralleled the systemic response (Table 3) . Specific anti-C. albicans IgA was detected in lung lavages of BALB/c, but not DBA/2 mice after primary i.n. infection. However, this pattern of local IgA production changed after a secondary i.n. infection with C. albicans MG3 as anti-C. albicans IgA was found in lung lavages of both strains of mice (Table 3) . immune responses can be evaluated after i.n. challenge, thus potentially allowing an analysis of the contribution of both of these arms of the immune response to protection against C. albicans infection originated from mucosal surfaces. DBA/2 mice (H_zd) have been shown previously to be more susceptible to i.v. C. albicans challenge than BALB/c mice (also H-2d) (Ashman et al., 1993; Hector et al., 1982; Romani et al., 1993) . This pattern of susceptibility was also apparent following i.n. challenge. BALB/c mice survived i.n. challenge with 3 x 106-3 x lo7 live yeast cells, while DBA/2 mice succumbed to a similar challenge in a dose-dependent manner. Interestingly, the C. albicans loads observed in the kidneys of dead DBA/2 mice after i.n. challenge resembled those detected in mice that succumbed to lethal i.v. challenge ( > 1 x lo4 c.f.u. per organ). In addition, DBA/2, but not BALB/c mice, also succumbed to i.n. challenge with four other C. albicans isolates, although C. albicans MG3, the isolate used in this study, exhibited the highest relative virulence (data not shown).
The course of C. albicans infection in intranasally challenged BALB/c and DBA/2 mice was also considerably different. In BALB/c mice C. albicans were cleared steadily from the lungs with no significant systemic spreading of the infection. In DBA/2 mice there was a delay in the initiation of C. albicans clearance from the lung and systemic C. albicans colonization was evident ( Fig. 1 and Table 2 ). Significant numbers of live C. albicans were recovered from the kidneys, spleen and liver of DBA/2 mice ( Cenci et a/., 1995) . Although comparable early inflammatory responses were elicited by i.n. C. albicans challenge in the lungs of BALB/c and DBA/2 mice, differences were observed between these murine strains in the rate of C. growth or from the discrete activation of a candidastatic rather than candidacidal immune mechanism. This mechanism was probably systemic rather than local to the lungs since colonization occurred in various organs simultaneously. DBA/2 mice are known to lack the complement molecule CS. Although this deficiency has been eliminated as a factor associated with their increased susceptibility to acute i.v. challenge (Sawyer, 1990; Ashman et al., 1991) , it may still play a role during mucosal infections.
Resistance to i.v. C. albicans challenge in BALB/c mice is accompanied by a T h l cellular response, while susceptibility of DBA/2 mice is associated with development of a Th2 response . Intragastrically challenged DBA/2 and BALB/c mice develop T h l and a combination of T h l and Th2 anti-C. albicans responses, respectively Cenci et al., 1995) . Challenge of mice by topical application of C. albicans in the oral mucosa generates detectable T-cell responses in DBA/2 but not BALB/c mice (Chakir et al., 1994) . In this study significant differences were found in the pattern of cytokine expression by C. albicans-activated splenocytes from intranasally infected BALB/c and DBA/2 mice. The cellular responses observed resemble those reported in the same mice upon intragastric C. albicans challenge Cenci et al., 1995) . As a result of i.n.
challenge, C. albicans-dependent IL4 and IL5 secretion was only detected in BALB/c splenocyte cultures, while C. albicans-dependent ILlO and IFNy secretion was detected in both BALB/c and DBA/2 splenocyte populations. The differences in cytokine response correlated with the anti-C. albicans antibody response of these mice. The presence of specific mucosal and serum IgA as well as IgGl responses in BALB/c, but not in DBA/2 mice could be attributed to the synthesis of IL5 and IL4 by BALB/c-, but not DBA/2-activated lymphocytes. Furthermore, the production of IgG3 and IgG2a in both mouse strains may be linked to the presence of comparable IFNy responses (Abbas et al., 1996) . The animal model of i.n. C. albicans infection described here could be explored further to determine the effect of mucosal antibody responses during C. albicans infection. Significantly, in this study resistant BALB/c, but not susceptible DBA/2 mice exhibited detectable levels of local mucosal and also humoral IgA against C. albicans after primary i.n. challenge. Interestingly, DBA/2 mice also exhibit defective production of IgA after intragastric, but not i.v. C. albicans challenge Cenci et al., 1995) .
In summary, the data presented here indicate the following. (i) Lethal systemic candidiasis may be induced in healthy adult mice by i.n. C. albicans challenge with no requirement for artificial immunosuppression or antibiotic treatment. (ii) i.n. C. albicans challenge results in transient lung colonization of both DBA/2 and Intranasal C. albicans infection BALB/c mice; however, only in DBA/2 mice is this accompanied by systemic spreading of the organism. (iii) i.n. C. albicans challenge elicits cellular immune responses in DBA/2 and BALB/c mice which resemble their respective responses to intragastric rather than i.v. challenge. (iv) After primary i.n. C. albicans infection, systemic and local anti-C. albicans IgA responses are detected in mice that rapidly clear the organism from their lungs (BALB/c), but not in those in which systemic spreading occurs (DBA/2).
T h e i.n. model of C. albicans infection is not based on clinical observations. Pulmonary candidiasis is a very rare occurrence in clinical practice. In humans systemic C. albicans infections are believed to originate in the intestinal rather that the respiratory tract. Nevertheless, the i.n. challenge model mirrors the early stage of this process, i.e. dissemination of the yeast from a mucosal surface. This process is by-passed by the most commonly used i.v. challenge model and cannot be reproduced in normal adult mice by oral challenge. The advantages of using an i.n. model of C. albicans infection have been highlighted recently (Fallon et al., 1997) . This model will be very valuable in studying the generation of systemic, and especially mucosal, immune responses during C. albicans colonization of mucosal surfaces as well as their contribution to prevention of systemic dissemination of infection.
